Inventor
DARIMONT BEATRICE DIANA
US35 patents
Patents
35 patentsUS10550188B2Feb 4, 2020
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC80 citations98
US10881743B2Jan 5, 2021
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC55 citations97
US11555190B2Jan 17, 2023
Compositions and methods of treating Facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC15 citations93
US11525137B2Dec 13, 2022
Compositions and methods of treating Facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC13 citations93
US10787519B2Sep 29, 2020
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC19 citations93
US10487149B2Nov 26, 2019
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC21 citations93
US11028179B2Jun 8, 2021
Anti-transferrin receptor antibodies and uses thereof
AVIDITY BIOSCIENCES INC16 citations92
US10913800B2Feb 9, 2021
Anti-transferrin receptor antibodies and uses thereof
AVIDITY BIOSCIENCES INC19 citations92
US11912779B2Feb 27, 2024
Compositions and methods of treating facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC6 citations85
US11576980B2Feb 14, 2023
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC6 citations85
US11446387B2Sep 20, 2022
Compositions and methods of treating muscle dystrophy
AVIDITY BIOSCIENCES INC8 citations85
US11253607B2Feb 22, 2022
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC7 citations85
US11246941B2Feb 15, 2022
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC7 citations85
US11554176B2Jan 17, 2023
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC2 citations84
US11497814B2Nov 15, 2022
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC3 citations84
US10800848B2Oct 13, 2020
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC7 citations83
US12427202B2Sep 30, 2025
Compositions and methods of treating muscle dystrophy
AVIDITY BIOSCIENCES INC1 citations74
US11834510B2Dec 5, 2023
Anti-transferrin receptor antibodies and uses thereof
AVIDITY BIOSCIENCES INC4 citations73
US11583591B2Feb 21, 2023
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC2 citations73
US12157774B2Dec 3, 2024
Compositions and methods of treating facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC1 citations72
US12104156B2Oct 1, 2024
Compositions and methods of treating facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC1 citations72
US12071485B2Aug 27, 2024
Compositions and methods of treating facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC2 citations72
US12049629B2Jul 30, 2024
Compositions and methods of treating Facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC2 citations72
US11999955B2Jun 4, 2024
Compositions and methods of treating facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC2 citations72
US11872287B2Jan 16, 2024
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC1 citations72
US11707532B2Jul 25, 2023
Compositions and methods of treating muscle dystrophy
AVIDITY BIOSCIENCES INC3 citations72
US12529056B2Jan 20, 2026
Compositions and methods of treating facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC0 citations62
US12497615B2Dec 16, 2025
Nucleic acid compositions and methods of multi-exon skipping
AVIDITY BIOSCIENCES INC0 citations62
US12486328B2Dec 2, 2025
Compositions and methods of treating facioscapulohumeral muscular dystrophy
AVIDITY BIOSCIENCES INC0 citations62
US12351637B2Jul 8, 2025
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC0 citations62
US12234290B2Feb 25, 2025
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC0 citations62
US11712478B2Aug 1, 2023
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC0 citations62
US12263224B2Apr 1, 2025
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC0 citations61
US12359202B2Jul 15, 2025
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
AVIDITY BIOSCIENCES INC1 citations58
US12071621B2Aug 27, 2024
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
AVIDITY BIOSCIENCES INC1 citations56